| Evotec SE. (3/21/22). "Press Release: Evotec Receives €3m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme". Hamburg. |
2022-03-21 |
| Nagi Bioscience S.A.. (3/21/22). "Press Release: The SERI-funded EIC Accelerator Program Grants Nagi Bioscience with €2.5 Million to Accelerate Development and Commercial Scale-up of Their Unique ‘Organism-on-Chip’ Product". Lausanne. |
2022-03-21 |
| Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets |
2022-03-21 |
| BigOmics Analytics S.A.. (3/17/22). "Press Release: BigOmics Closes Pre-Series A with Additional Investment from Eppendorf". Lugano. |
2022-03-17 |
| Bruker Corporation. (3/16/22). "Press Release: Bruker Appoints Philip Ma to Its Board of Directors". Billerica, MA. |
2022-03-16 |
| Immunic, Inc.. (3/16/22). "Press Release: Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer". New York, NY. |
2022-03-16 |
| Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. |
2022-03-16 |
| InfanDx AG. (3/15/22). "Press Release: Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A". Cologne & Boston, MA. |
2022-03-15 |
| Adrenomed AG. (3/15/22). "Press Release: Adrenomed Supervisory Board Appoints Dr. Richard Jones as CEO". Hennigsdorf. |
2022-03-15 |
| Temedica GmbH. (3/15/22). "Press Release: Temedica Announces Cooperation with Bristol Myers Squibb for the Development of a Digital Companion for Psoriasis Patients". Munich. |
2022-03-15 |
| Bruker Corporation. (3/15/22). "Press Release: Bruker Leads $46 Million New Financing Round for PrognomiQ to Advance Development of Next-Generation Multi-omics Liquid Biopsy Products for Cancer". San Mateo, CA. |
2022-03-15 |
| Ginkgo Bioworks Inc.. (3/14/22). "Press Release: Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-high-throughput Screening Platform". Boston, MA & Basel. |
2022-03-14 |
| Ayoxxa Biosystems GmbH. (3/14/22). "Press Release: Ayoxxa Receives Fresh Capital for Commercial Growth in Europe, US and Asia Led by Prosnav Capital". Cologne. |
2022-03-14 |
| Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. |
2022-03-14 |
| MedXCell S.A.. (3/11/22). "Press Release: MedXCell SA Is Proud to Annonce the Arrival of Andrew Galzaka and John D. McMannis as New Members of the Board and Pierre J.Magistretti as New Scientific Advisor". Montreux. |
2022-03-11 |
| MorphoSys AG. (3/10/22). "Press Release (Ad hoc): MorphoSys AG Reports Non-cash Impairment Charge of approx. € 231 Million on Goodwill after Consolidation of Research and Discovery Functions, Corresponding Increase of Group Operating Expenses in 2021". P |
2022-03-10 |
| Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. |
2022-03-10 |
| Heidelberg Pharma AG. (3/10/22). "Press Release: Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117". Ladenburg. |
2022-03-10 |
| Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim. |
2022-03-08 |
| BioNTech SE. (3/8/22). "Press Release: BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo (cemiplimab) Combination in NSCLC". Mainz. |
2022-03-08 |
| Enzymicals AG. (3/8/22). "Press Release: Enzymicals AG Board of Supervisors Appoints New Management with Dr. Erik de Vries as CEO". Greifswald. |
2022-03-08 |
| Solvias AG. (3/8/22). "Press Release: Solvias Appoints Archie Cullen Chief Executive Officer". Kaiseraugst. |
2022-03-08 |
| Singleron Biotechnologies. (3/7/22). "Press Release: Singleron Acquires Proteona". Nanjing, Suzhou, Cologne & Singapore. |
2022-03-07 |
| Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". |
2022-03-07 |
| LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf. |
2022-03-07 |
| Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. |
2022-03-07 |
| InxMed Co., Ltd.. (3/4/22). "Press Release: InxMed Raised $50 Million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers". Nanjing. |
2022-03-04 |
| ArrePath. (3/3/22). "Press Release: ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance". Princeton, NJ. |
2022-03-03 |
| Epsilogen Ltd.. (3/2/22). "Press Release: Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing". London. |
2022-03-02 |
| Ampersand Capital Partners. (3/1/22). "Press Release: BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners". Cologne. |
2022-03-01 |
| CureVac N.V.. (3/1/22). "Press Release: CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer". Tübingen & Boston, MA. |
2022-03-01 |
| ECBF Management GmbH. (3/1/22). "Press Release: €34M to End Chick Culling. Impact Fund ECBF Invests In AgTech In Ovo". Luxembourg. |
2022-03-01 |
| EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". |
2022-03-01 |
| Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg. |
2022-02-28 |
| Editas Medicine, Inc.. (2/28/22). "Press Release: Editas Medicine Announces Favorable Decision from U.S. Patent and Trademark Office in CRISPR Patent Interference". Cambridge, MA. |
2022-02-28 |
| Evolva Holding S.A.. (2/28/22). "Press Release: Carsten Däweritz Remains CFO of Evolva". Reinach. |
2022-02-28 |
| Medigene AG. (2/25/22). "Press Release: Dr. Selwyn Ho Appointed New CEO of Medigene". Lisbon. |
2022-02-25 |
| Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. |
2022-02-24 |
| ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. |
2022-02-23 |
| Poseida Therapeutics, Inc.. (2/22/22). "Press Release: Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy". San Diego, CA. |
2022-02-22 |
| FZI Forschungszentrum Informatik. (2/21/22). "Press Release: Busy Bees in Search of Data. OCELI Project Makes Causes of Bee Mortality Measurable". Karlsruhe. |
2022-02-21 |
| Valneva S.E.. (2/21/22). "Press Release: Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development". Saint-Herblain. |
2022-02-21 |
| BioNTech SE. (2/21/22). "Press Release: BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer". Mainz & Martinsried. |
2022-02-21 |
| Vibalogics GmbH. (2/18/22). "Press Release: Vibalogics Acquired by Top Global CDMO Recipharm AB". |
2022-02-18 |
| Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. |
2022-02-17 |
| Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg. |
2022-02-17 |
| SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. |
2022-02-16 |
| Climedo Health GmbH. (2/16/22). "Press Release: Climedo Closes €5 Million Seed Financing Round". Munich. |
2022-02-16 |
| ITM Isotope Technologies Munich SE. (2/16/22). "Press Release: ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma". Garching & Hong Kong. |
2022-02-16 |
| Centauri Therapeutics Ltd.. (2/16/22). "Press Release: Centauri Therapeutics Closes £24 million GBP Series A Investment Round". London. |
2022-02-16 |
| XO Life GmbH. (2/16/22). "Press Release: Two Million Euros for XO Life GmbH’s Patient Insights Platform". Berlin & Munich. |
2022-02-16 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (2/15/22). "Press Release: SHS Sells Leading Enzyme Engineering Company c-LEcta GmbH to Kerry Group". Tübingen. |
2022-02-15 |
| Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg. |
2022-02-15 |
| Kerry Group plc. (2/15/22). "Press Release: Kerry Announces Significant Strategic Biotechnology Acquisitions". |
2022-02-15 |
| NMD Pharma A/S. (2/15/22). "Press Release: NMD Pharma Raises €35 Million in a New Financing". Aarhus. |
2022-02-15 |
| c-LEcta GmbH. (2/15/22). "Press Release: c-LEcta Announces that it Has Reached Agreement to Be Acquired by Kerry Group". |
2022-02-15 |
| IMIdomics, Inc.. (2/15/22). "Press Release: IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE". San Rafael, CA & Barcelona. |
2022-02-15 |
| ProBioGen AG. (2/11/22). "Press Release: ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology". Berlin. |
2022-02-11 |
| Green Elephant Biotech GmbH. (2/11/22). "Press Release: Pre-seed Funding Round for Green Elephant Biotech. BMH Invests in Developer of Sustainable Cell Cultivation Systems". Wiesbaden & Gießen. |
2022-02-11 |
| Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. |
2022-02-10 |
| Haya Therapeutics S.A.. (2/9/22). "Press Release: Haya Therapeutics Establishes U.S. Location. Haya Closes US$5M Seed Extension". Lausanne & San Diego, CA. |
2022-02-09 |
| Lindis Blood Care GmbH. (2/9/22). "Press Release: Lindis Blood Care Successfully Closes Follow-on Financing Round". Hennigsdorf. |
2022-02-09 |
| AiCuris Anti-infective Cures AG. (2/9/22). "Press Release: AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-acting RNA-based Therapy against BK Virus". Wuppertal & Leiden. |
2022-02-09 |
| Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA. |
2022-02-09 |
| ECBF Management GmbH. (2/9/22). "Press Release: Insect Scale-up Protix Raises 50 Million for Expansion and Development from International Investors". Wuppertal & Leiden. |
2022-02-09 |
| BRAIN Biotech AG. (2/8/22). "Press Release: BRAIN Biotech and Formo. Strategic Partnership of European Biotech Experts for the Production of Animal-free Milk Protein". Zwingenberg. |
2022-02-08 |
| Inova Software S.A.S.. (2/8/22). "Press Release: Inova Acquires In-Part, Matchmaking Platform for Academia-Industry Collaboration". Lyon. |
2022-02-08 |
| Evolva Holding S.A.. (2/8/22). "Press Release: Evolva Appoints Christian Wichert as New CEO to Boost Growth Strategy and Enter Its Next Phase of Development and Commercialization". Reinach. |
2022-02-08 |
| ECBF Management GmbH. (2/7/22). "Press Release: ECBF Invests in the €16M VC Round of Elicit Plant, France, to Accelerate Commercialization of Their Water Stress Management Solutions for Field Crops Internationally". Luxembourg. |
2022-02-07 |
| Merck KGaA. (2/7/22). "Press Release: Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth". Darmstadt. |
2022-02-07 |
| AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA. |
2022-02-07 |
| Bayer AG. (2/4/22). "Press Release: Bayer Will Discontinue Phase II Development Candidate eliapixant [only for specialized press]". Berlin. |
2022-02-04 |
| Evotec SE. (2/4/22). "Press Release: Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to All P2X3 Assets [Ad hoc release]". Hamburg. |
2022-02-04 |
| iOmx Therapeutics AG. (2/3/22). "Press Release: iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development". Martinsried. |
2022-02-03 |
| eTheRNA Immunotherapeutics N.V.. (2/3/22). "Press Release: eTheRNA Announces Research Agreement with Merck to Access mRNA technologies". Niel. |
2022-02-03 |
| Nemis Technologies AG. (2/3/22). "Press Release: Nemis Technologies AG Closes a CHF 7.75 Million Series A Funding Round". Dübendorf. |
2022-02-03 |
| Bayer AG. (2/3/22). "Press Release: Bayer Appoints Christine Roth as New Head of Oncology Strategic Business Unit at Pharmaceuticals Division". Berlin. |
2022-02-03 |
| BRAIN Biotech AG. (2/2/22). "Press Release: AnalytiCon Discovery and Pharvaris Extend Their Collaboration". Potsdam. |
2022-02-02 |
| Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts". |
2022-02-02 |
| Brainomix Ltd.. (2/1/22). "Press Release: Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-powered Radiomic Software for Automated Assessment of Solid Tumor Cancer". Oxford. |
2022-02-01 |
| HH2E AG. (2/1/22). "Press Release: HH2E, New Strong Player in the German Green Energy Sector. HH2E Plans Investments of €2.7 Billion (CAPEX) in Projects in Germany". |
2022-02-01 |
| Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo. |
2022-02-01 |
| Centogene N.V.. (2/1/22). "Press Release: Centogene Announces Nomination of Kim Stratton as Chief Executive Officer". Cambridge, MA, Rostock & Berlin. |
2022-02-01 |
| Zetta Genomics Ltd.. (2/1/22). "Press Release (News): Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY. |
2022-02-01 |
| BRAIN Biotech AG. (2/1/22). "Press Release: BRAIN Group Significantly Expands Its Food Enzyme Business with the Acquisition of Breatec B.V. and Comix Business". Zwingenberg. |
2022-02-01 |
| Temedica GmbH. (2/1/22). "Press Release: Temedica Partners with Noventi to Enhance Permea-generated Insights to Improve Patient Care". Munich. |
2022-02-01 |
| Centogene N.V.. (2/1/22). "Press Release: Centogene Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan". Cambridge, MA, Rostock & Berlin. |
2022-02-01 |
| Roche. (2/1/22). "Press Release: Changes to the Roche Board of Directors and the Corporate Executive Committee". Basel. |
2022-02-01 |
| Ethris GmbH. (2/1/22). "Press Release: Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases". Munich. |
2022-02-01 |
| Gandeeva Therapeutics, Inc.. (1/31/22). "Press Release: Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions". Vancouver, BC. |
2022-01-31 |
| Leo Pharma A/S. (1/31/22). "Press Release: Leo Pharma Appoints Christophe Bourdon as New CEO". Ballerup. |
2022-01-31 |
| Glooko, Inc.. (1/31/22). "Press Release: Glooko Acquires Germany-Based xbird, a Medical AI Company". Berlin & Palo Alto, CA. |
2022-01-31 |
| Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. |
2022-01-31 |
| Mainz Biomed N.V.. (1/28/22). "Press Release: Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares". Berkeley, CA & Mainz. |
2022-01-28 |
| Mainz Biomed N.V.. (1/27/22). "Press Release: Mainz Biomed Appoints Steve Quinn as VP Business Development". Berkeley & Mainz. |
2022-01-27 |
| Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development". |
2022-01-26 |
| Cellino Biotech, Inc.. (1/25/22). "Press Release: Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing". Cambridge, MA & Leverkusen. |
2022-01-25 |
| Cytovation AS. (1/25/22). "Press Release: Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy". Bergen. |
2022-01-25 |
| InstaDeep. (1/25/22). "Press Release: InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems". London. |
2022-01-25 |
| genOway S.A.. (1/25/22). "Press Release: genOway Grants the Leading UK Academic Research Funder a Non-exclusive License for CRISPR/Cas9 Technology". Lyon. |
2022-01-25 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px](/banner/iito-business-intelligence-20220406-650-100-promote-brand-to-decision-makers.jpg)
1 2 3 4 ... 66 67 68 
Date![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
